Eastgate Biotech Corp Stock Market Value
| ETBI Stock | USD 0 0.00 0.00% |
| Symbol | Eastgate |
Eastgate Biotech Corp Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eastgate Biotech. If investors know Eastgate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eastgate Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.01) |
The market value of Eastgate Biotech Corp is measured differently than its book value, which is the value of Eastgate that is recorded on the company's balance sheet. Investors also form their own opinion of Eastgate Biotech's value that differs from its market value or its book value, called intrinsic value, which is Eastgate Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eastgate Biotech's market value can be influenced by many factors that don't directly affect Eastgate Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eastgate Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eastgate Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eastgate Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Eastgate Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Eastgate Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Eastgate Biotech.
| 02/17/2024 |
| 01/07/2026 |
If you would invest 0.00 in Eastgate Biotech on February 17, 2024 and sell it all today you would earn a total of 0.00 from holding Eastgate Biotech Corp or generate 0.0% return on investment in Eastgate Biotech over 690 days. Eastgate Biotech Corp., a development stage company, develops novel formulations of natural compounds and pharmaceutical... More
Eastgate Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Eastgate Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Eastgate Biotech Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.2071 | |||
| Maximum Drawdown | 2996.67 | |||
| Value At Risk | (73.33) |
Eastgate Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Eastgate Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Eastgate Biotech's standard deviation. In reality, there are many statistical measures that can use Eastgate Biotech historical prices to predict the future Eastgate Biotech's volatility.| Risk Adjusted Performance | 0.1617 | |||
| Jensen Alpha | 129.62 | |||
| Total Risk Alpha | 55.08 | |||
| Treynor Ratio | (3.40) |
Eastgate Biotech Corp Backtested Returns
Eastgate Biotech is out of control given 3 months investment horizon. Eastgate Biotech Corp secures Sharpe Ratio (or Efficiency) of 0.16, which denotes the company had a 0.16 % return per unit of risk over the last 3 months. We have analyzed eighteen different technical indicators, which can help you to evaluate if expected returns of 28.1% are justified by taking the suggested risk. Use Eastgate Biotech Mean Deviation of 252.14, variance of 372405.78, and Standard Deviation of 610.25 to evaluate company specific risk that cannot be diversified away. Eastgate Biotech holds a performance score of 12 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -37.15, which means a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Eastgate Biotech are expected to decrease by larger amounts. On the other hand, during market turmoil, Eastgate Biotech is expected to outperform it. Use Eastgate Biotech jensen alpha, kurtosis, as well as the relationship between the Kurtosis and relative strength index , to analyze future returns on Eastgate Biotech.
Auto-correlation | -0.02 |
Very weak reverse predictability
Eastgate Biotech Corp has very weak reverse predictability. Overlapping area represents the amount of predictability between Eastgate Biotech time series from 17th of February 2024 to 27th of January 2025 and 27th of January 2025 to 7th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Eastgate Biotech Corp price movement. The serial correlation of -0.02 indicates that only 2.0% of current Eastgate Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.02 | |
| Spearman Rank Test | 0.11 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Eastgate Biotech Corp lagged returns against current returns
Autocorrelation, which is Eastgate Biotech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Eastgate Biotech's stock expected returns. We can calculate the autocorrelation of Eastgate Biotech returns to help us make a trade decision. For example, suppose you find that Eastgate Biotech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Eastgate Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Eastgate Biotech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Eastgate Biotech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Eastgate Biotech stock over time.
Current vs Lagged Prices |
| Timeline |
Eastgate Biotech Lagged Returns
When evaluating Eastgate Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Eastgate Biotech stock have on its future price. Eastgate Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Eastgate Biotech autocorrelation shows the relationship between Eastgate Biotech stock current value and its past values and can show if there is a momentum factor associated with investing in Eastgate Biotech Corp.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Eastgate Biotech Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eastgate Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eastgate Biotech Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eastgate Biotech Corp Stock:Check out Eastgate Biotech Correlation, Eastgate Biotech Volatility and Eastgate Biotech Alpha and Beta module to complement your research on Eastgate Biotech. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Eastgate Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.